Cannabis policy moved on three consequential fronts over the past 24 hours. A new federal bill proposes a wholesale rewrite of drug scheduling, California disclosed the scale of its latest illicit-market enforcement campaign, and a New York appeals court upheld the state’s ability to finance social-equity dispensaries.
Congressman Introduces Sweeping Bill to Deschedule Marijuana and Rewrite Federal Drug Law
Rep. Steve Cohen of Tennessee introduced the Public Health and Research Reforms in Controlled Substances Act, a broad proposal that would remove marijuana from the federal Controlled Substances Act and substantially restructure the system used to classify drugs.
The measure would shift key scheduling and research responsibilities from the Department of Justice to the Department of Health and Human Services, establish a more detailed framework for evaluating risks and medical benefits, create blanket research licenses and eliminate weight-based mandatory minimum drug penalties. It also directs the U.S. Sentencing Commission to account for the changes and provide a path for retroactive sentencing relief.
Introducing the legislation does not change marijuana’s current legal status, and the proposal would still need to advance through Congress. Its scope nevertheless distinguishes it from narrower rescheduling measures by treating cannabis reform as part of a larger overhaul of federal drug regulation, research and sentencing.
Why It Matters: Analysis: Descheduling would carry significantly broader implications for cannabis businesses than moving marijuana between federal schedules. Although the bill’s legislative prospects remain uncertain, it establishes an expansive policy benchmark covering legalization, research access, regulatory authority and criminal penalties.
Source: Office of Rep. Steve Cohen
California Reports More Than $230 Million in Illicit Cannabis Seized or Destroyed
California authorities seized or destroyed 139,293 pounds of illicit cannabis valued by the state at more than $230 million during the first nine months of 2026, according to figures released by Gov. Gavin Newsom’s office. The Unified Cannabis Enforcement Task Force also eradicated 236,846 plants during that period.
Third-quarter operations accounted for more than $91 million of the estimated product value, 55,308 pounds of cannabis and 108,226 plants. The state reported enforcement activity across nine counties, including a three-day Lancaster-area operation that resulted in approximately 16,760 pounds of cannabis being seized and more than 33,000 plants eradicated.
Since the task force was established in 2022, California says participating agencies have seized or destroyed illicit cannabis valued at more than $1.47 billion. The task force is co-chaired by the Department of Cannabis Control and Department of Fish and Wildlife, with coordination from the Governor’s Office of Emergency Services.
Why It Matters: Analysis: California’s licensed operators continue to compete against a large unregulated market that avoids state taxes, testing requirements and compliance expenses. The figures demonstrate substantial enforcement activity, but they also underscore the enduring scale of illicit production—particularly in Los Angeles County and other major cultivation regions.
Source: Office of Governor Gavin Newsom
New York Appeals Court Upholds State Financing for Social-Equity Dispensaries
A New York appellate court affirmed the dismissal of a lawsuit seeking to stop the use of state funds to finance and develop conditional adult-use retail dispensaries operated by social-equity licensees.
The plaintiffs argued that New York’s financing framework conflicted with the federal Controlled Substances Act and was therefore preempted. The Appellate Division’s Third Department rejected that argument, finding that the funding program does not require anyone to violate federal law, provide immunity from federal enforcement or prevent federal authorities from enforcing the Controlled Substances Act.
The ruling preserves the challenged framework supporting dispensary locations developed through the New York Social Equity Cannabis Investment Fund. It also reinforces an earlier state appellate decision rejecting a similar federal-preemption challenge to New York’s cannabis regulations.
Why It Matters: Analysis: The decision removes an immediate legal threat to a financing structure intended to help qualifying operators enter New York’s capital-intensive retail market. More broadly, it strengthens the state’s defense against claims that federal prohibition automatically invalidates state cannabis regulation or financial support programs.
Source: New York Supreme Court, Appellate Division opinion via Justia
What We’re Watching
Over the next 24 to 72 hours, watch for initial congressional support or committee action on the Cohen proposal, any indication that the New York plaintiffs will pursue another appeal, and a ruling from the Texas litigation challenging the state’s treatment of THCA products. Additional enforcement disclosures from California could also clarify how much of the reported illicit inventory was connected to organized operations rather than smaller unlicensed businesses.
